key: cord-0053850-3gan0m33 authors: Kumar, Yashwant; Yadav, Reena; Bhatia, Alka title: Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? date: 2020-12-15 journal: nan DOI: 10.2217/fvl-2020-0210 sha: 422a9c84a02d7f3a8111d0be52f5c3f4c88d7bbe doc_id: 53850 cord_uid: 3gan0m33 nan methods or the combination of above two to synthesize the pharmaceutically active ingredients like ursodeoxycholic acid. The latter was initially obtained from bile of black bear; however, subsequently, it was synthesized by chemical transformation in industries by using ketolithocholic acid as the precursor. The chemical method initially used involved reduction in n-propyl alcohol and metallic sodium; however, several modifications in the protocol have been done since then to increase the yield of ursodeoxycholic acid. Nowadays, cholic acid obtained from bovine source is used as a precursor for its synthesis [7] . Currently, bile acids are being used parenterally, orally as well as inhalationally for various cholestatic and other diseases. In the latter route, the bile salts have been found to affect the porosity of nanoformulations leading to aerodynamic properties which facilitate drug delivery into the lungs [8, 9] . Bile acids are steroids synthesized from cholesterol in the hepatocytes and after conjugation with glycine and taurine are secreted in bile as bile salts. Conjugation makes them amphiphilic with both hydrophobic and hydrophilic properties. They later undergo enterohepatic circulation and help in the absorption of fat through micelle formation. Cholic acid and chenodeoxycholic acid are known as the primary bile acids whereas deoxycholic acid and lithocholic acid are the secondary bile acids formed by the action of bacteria in the intestine. Ursodeoxycholic acid, an epimer of chenodeoxycholic acid, is synthesized from it by dehydroxylation. It is considered as the most hydrophilic type of bile acid. Besides fat emulsification, bile salts have also been demonstrated to sub serve different metabolic functions in the body owing to the activation of different signaling pathways [10] . The following attributes may make bile acids suitable for SARS-CoV-2 targeting: • First, the bile acids have been proposed to possess anti-inflammatory properties that may prove beneficial in curbing the cytokine storm believed to be involved in the pathogenicity of the virus. Immune modulation is believed to occur via involvement of Farnesoid X or the G-coupled receptor TGR5 at the outer plasma membrane. A study in cholestatic mice showed that excess bile acids in serum reduced the recruitment of monocytes and NK cells to the liver [11] . Another study revealed that bile acids, when modified by intestinal bacteria, may help in regulating the Treg numbers by altering the relevant immune signaling pathways [12] ; • Second, bile acids have membrane permeability altering properties due to which they are extensively researched as drug carriers. Due to their amphiphilic nature, they are believed to act as ideal drug transporters. In the context of SARS-CoV-2, they may serve to increase the intracellular delivery and concentration of drugs like remdesivir or other antivirals when chemically conjugated to them [13] . Studies have shown that bile acids can be used intranasally though in low concentration (<0.3%) to facilitate absorption of other drugs, however, higher concentrations are believed to cause nasal irritation [14] . A study in rabbits showed that sodium tauroglycocholate increases the extent of nasal absorption of the antiviral drug acyclovir from 10% in the controls to 14.5%. This highlights their potential to be used in various inhalational formulations to fight the respiratory viruses [15] ; • Third, it is known that the entry of viruses into the cell is blocked by drugs inhibiting viral envelope proteins or viral and entry receptor protein-protein interactions or protein-lipid interactions. Previous studies have shown that bile acids can incorporate themselves in between the membrane lipids thus altering their distribution and also the function of proteins attached to them [16] . In our preliminary work on chenodeoxycholic and ursodeoxycholic acid, the above bile acids were found to bind with receptor binding domain of S-glycoprotein of SARS-CoV-2 with negative binding energies (data not shown). This shows that bile acids have the potential to bind to SARS-CoV-2; however, the impact of their binding on the virus and its infectivity (ability to enter the cells) remains to be investigated; • Fourth, some authors have proposed that bile acids may have virus replication modulating properties particularly in the context of hepatotropic viruses owing to activation of different signaling pathways and transcription factors [17] . Whether or not the bile acids can strip SARS-CoV-2 of its envelope by targeting its lipoprotein components, thus, destroying it completely remains interesting (though wishful thinking as of now) arena to explore. A possible, although weak clue in favor of their protective role in SARS-CoV-2 infection may be that in the intestine the virus is less active due to the presence of bile acids. Therefore, though the gastrointestinal symptoms may be present they may appear late and are rarely life threatening. Also, there is no clear evidence for the affection of the liver or gall bladder by the virus despite the presence of ACE2R in these organs [18] . Literature search on the role of bile acids/salts specifically in the context of the respiratory system reveals studies mostly on manifestations after aspiration of bile acids and associated toxicity in cholestatic conditions or otherwise. Various toxic manifestations cited in these studies range from the increased propensity of respiratory infections to airway inflammation and pulmonary fibrosis [19] [20] [21] . A study by Aldhahrani et al. on human bronchial epithelial cell line (BEAS-2) showed that different bile acids in a concentration of 10-30 μm/l resulted in cell death and increased release of IL-6 and IL-8 [22] . However, in the above studies, the aspirated material was composed of a mixture of bile acids, cholesterol, gastric acid, etc., rather than bile acids alone. Further, a more recent study on inhalable albendazole conjugated with bile salts was not found to disturb lung surfactant function and aerodynamics in any way. Also, a study on house dust mite-induced mice models of allergic airway disease and human subjects with asthma demonstrated that conjugated bile salts via nasopharyngeal route have the potential to decrease airway inflammation [23] . Ursodeoxycholic acid is considered to be the least toxic bile acid due to its hydrophilic nature [24] . Perhaps, the dosage and type of bile acid (more hydrophobic or hydrophilic) needs to be standardized to least irritant and toxic levels before contemplating them as either standalone or combinatorial inhalational therapeutics in case of coronavirus disease-19. Thus, whether naturally acting detergents like bile acids/salts can help in stripping off the envelope of SARS-CoV-2 thereby disrupting its assembly is a million-dollar question. Although a review of past literature and logical thinking throws light on their potential benefit, only time and an experimental proof will be able to provide definitive answers to the above. Future studies may be planned with special emphasis not only on investigating their probable benefit but also on understanding issues like exact mechanism of action and administration strategies etc. However, we believe that it is worthwhile to investigate them as one of the many potential inhalation based preventive or therapeutic candidates for further research and study. Author contributions Y Kumar, R Yadav & A Bhatia contributed equally to conceptualization, design and drafting of the final version of the manuscript. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript. Sars-CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics? Coronavirus envelope protein: current knowledge Viruses and lipids Why does soap work so well on SARS CoV 2? Bile acids modulate signaling by functional perturbation of plasma membrane domains Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine Syntheses of ursodeoxycholicacid and its conjugated bile acid Semisynthetic bile acids: a new therapeutic option for metabolic syndrome The influence of surfactant on the properties of albendazole-bile salts particles designed for lung delivery Bile Secretion Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice Bile acid metabolites control TH17 and Treg cell differentiation Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles Intracellular drug bioavailability: a new predictor of system dependent drug disposition Application of bile acids in drug formulation and delivery. Front Bile acid induces hydrophobicity-dependent membrane alterations Bile acid-induced modulation of virus replication Gastrointestinal and liver manifestations of COVID-19 Bile signalling promotes chronic respiratory infections and antibiotic tolerance Pulmonary complications of gastric fluid and bile salts aspiration: an experimental study in rat Bile salt enhancers for inhalation: correlation between in vitro and in vivo lung effects Effects of bile acids on human airway epithelial cells: implications for aerodigestive diseases Conjugated bile acids attenuate allergen-induced airway inflammation and hyperresposiveness by inhibiting UPR transducers Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart